Get the Stockscreener App
11.00
1.99%
-0.05
Elicio Therapeutics Inc stock is traded at $11.00, with a volume of 1,923.
It is down -1.99% in the last 24 hours and down -1.81% over the past month.
Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking.
See More
Previous Close:
$11.05
Open:
$11
24h Volume:
1,923
Relative Volume:
0.02
Market Cap:
$179.72M
Revenue:
-
Net Income/Loss:
$-33.82M
P/E Ratio:
-0.4299
EPS:
-25.5891
Net Cash Flow:
$-66.04M
1W Performance:
-5.54%
1M Performance:
-1.81%
6M Performance:
+30.32%
1Y Performance:
+114.03%
1-Day Range:
$11.00
$11.00
1-Week Range:
$10.90
$11.62
52-Week Range:
$4.05
$12.62
Elicio Therapeutics Inc Stock (ELTX) Company Profile
Name
Elicio Therapeutics Inc
Sector
Industry
Phone
(857) 209-0050
Address
451 D STREET, 5TH FLOOR, BOSTON
Compare ELTX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ELTX
Elicio Therapeutics Inc
|
11.00 | 181.19M | 0 | -33.82M | -66.04M | -25.59 |
|
VRTX
Vertex Pharmaceuticals Inc
|
385.69 | 97.36B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
578.28 | 60.19B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.14 | 59.56B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
718.57 | 44.94B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
330.14 | 36.14B | 3.81B | -644.79M | -669.77M | -6.24 |
Elicio Therapeutics Inc Stock (ELTX) Latest News
Using R and stats models for Elicio Therapeutics Inc. forecasting2025 Support & Resistance & Safe Entry Trade Signal Reports - newser.com
Applying Elliott Wave Theory to Elicio Therapeutics Inc.July 2025 Trends & Technical Analysis for Trade Confirmation - newser.com
How moving averages guide Elicio Therapeutics Inc. tradingJuly 2025 Weekly Recap & Verified Momentum Stock Ideas - newser.com
What technical models suggest about Elicio Therapeutics Inc.’s comeback2025 Risk Factors & Expert Approved Momentum Ideas - newser.com
Is Elicio Therapeutics Inc. still worth holding after the dip2025 Market Outlook & AI Forecasted Entry/Exit Points - newser.com
How to use a screener to detect Elicio Therapeutics Inc. breakouts2025 Breakouts & Breakdowns & Risk Managed Investment Entry Signals - newser.com
Is Elicio Therapeutics Inc. building a consolidation baseWeekly Trend Report & Daily Profit Focused Stock Screening - newser.com
Multi factor analysis applied to Elicio Therapeutics Inc.IPO Watch & Daily Profit Maximizing Tips - newser.com
How sentiment analysis helps forecast Elicio Therapeutics Inc.Quarterly Risk Review & Free Real-Time Market Sentiment Alerts - newser.com
Elicio Therapeutics Hits New 52-Week High of $12.61 - Markets Mojo
ETF Watch: Can Elicio Therapeutics Inc lead its sector in growth2025 Short Interest & Community Verified Swing Trade Signals - خودرو بانک
Will earnings trigger a reversal in Elicio Therapeutics Inc.2025 Macro Impact & Daily Entry Point Trade Alerts - newser.com
Retail Surge: Can TOON expand into new marketsJuly 2025 Spike Watch & Detailed Earnings Play Alerts - khodrobank.com
Technical analysis overview for Elicio Therapeutics Inc. stockMarket Risk Report & Smart Investment Allocation Tips - newser.com
Top chart patterns to watch in Elicio Therapeutics Inc.July 2025 Recap & AI Based Trade Execution Alerts - newser.com
Smart Money: Is Elicio Therapeutics Inc stock suitable for long term investingWatch List & Free Weekly Watchlist of Top Performers - خودرو بانک
Elicio Therapeutics reports inducement grants - TipRanks
Is Elicio Therapeutics Inc. showing signs of accumulationJuly 2025 Momentum & Weekly Stock Performance Updates - newser.com
Published on: 2025-09-18 22:03:11 - newser.com
Technical signs of recovery in Elicio Therapeutics Inc.Jobs Report & Growth Oriented Trading Recommendations - newser.com
Rate Hike: Whats next for Elicio Therapeutics Inc stockTrade Performance Summary & High Accuracy Swing Trade Signals - خودرو بانک
Is now a turning point for Elicio Therapeutics Inc.Weekly Market Report & Expert Curated Trade Setup Alerts - newser.com
Is it time to cut losses on Elicio Therapeutics Inc.July 2025 Retail & Accurate Trade Setup Notifications - newser.com
Elicio Therapeutics : AMPLIFY-7P Phase 2 Immunogenicity Data - MarketScreener
Elicio Therapeutics Reports Inducement Grants - GlobeNewswire
Cancer Vaccine Developer Elicio Therapeutics Awards Stock Options to Expand Research Team - Stock Titan
Risk Check: Does Elicio Therapeutics Inc. have declining or rising EPSMarket Sentiment Review & Fast Exit and Entry Trade Guides - خودرو بانک
Retail Surge: Is Elicio Therapeutics Inc. impacted by rising rates - khodrobank.com
Will Elicio Therapeutics Inc. stock recover after recent dropTrade Signal Summary & Daily Chart Pattern Signal Reports - newser.com
Elicio Therapeutics Announces Promising Phase 2 Vaccine Results - TipRanks
Elicio’s cancer vaccine ELI-002 shows strong immune response in 99% of patients - Investing.com Canada
Elicio Therapeutics Reports 99% mKRAS-Specific T Cell Response in Phase 2 AMPLIFY-7P Trial of ELI-002 Vaccine - Quiver Quantitative
Elicio Therapeutics Reports ELI-002 7P Achieved Robust - GlobeNewswire
145-fold Immune Response Boost: Elicio's Cancer Vaccine Shows Remarkable 99% Success Rate in Phase 2 Study - Stock Titan
Aug Action: Can Elicio Therapeutics Inc. stock double in the next yearJuly 2025 Volume & Free Expert Approved Momentum Trade Ideas - خودرو بانک
What are the future prospects of Elicio Therapeutics IncTrade Volume Summary & Technical Pattern Alert System - خودرو بانک
Momentum Shift: What is Elicio Therapeutics Inc.’s book value per shareEarnings Overview Summary & Verified Momentum Stock Watchlist - خودرو بانک
Earnings Update: How do insiders feel about Elicio Therapeutics IncMarket Performance Report & Consistent Growth Equity Picks - خودرو بانک
Published on: 2025-09-15 22:50:51 - newser.com
Growth Review: What are the future prospects of Elicio Therapeutics IncMarket Volume Report & High Conviction Investment Ideas - خودرو بانک
Elicio Therapeutics Inc Stock (ELTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.20%
0.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):